
The US Justice Department has revealed that American drugs company Johnson & Johnson has agreed to pay over $2.2 billion as part of the settlement of allegations over its marketing techniques.
The company had been accused of paying incentives to doctors and pharmacies in order to promote three of its medicines, including anti-psychotic drugs Risperdal and Invega and heart drug Natrecor.
The company has also been accused of promoting drugs for uses not officially allowed.
Source: Medindia
Advertisement
|
Latest Drug News




